Literature DB >> 27176616

Therapeutic options following pneumonectomy in non-small cell lung cancer.

Francesco Petrella1, Lorenzo Spaggiari1,2.   

Abstract

INTRODUCTION: Pneumonectomy can be considered the most appropriate treatment for lung cancer that cannot be removed by lesser resection on. AREAS COVERED: Therapeutic options following pneumonectomy may be required at least in 3 different scenarios: 1) an early approach due to acute surgical complications 2) a late approach due to chronic surgical complications 3) an integrated radio-chemotherapeutic adjuvant approach for advanced stages. In this review we focused on these three settings with particular emphasis to surgical approach as well as to alternative options. Expert commentary: Pneumonectomy itself does not preclude postoperative additional treatments, if needed, to maximize oncological results and to manage potential short or long term complications. However, as pneumonectomy puts a significant physiological stress on the respiratory and circulatory systems, the benefits and risks of pneumonectomy should be compared with those of alternative, non-resectional treatment modalities.

Entities:  

Keywords:  Pneumonectomy; adjuvant chemotherapy; radiotherapy; single-lung surgery; thermal ablation

Mesh:

Year:  2016        PMID: 27176616     DOI: 10.1080/17476348.2016.1188694

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  6 in total

1.  A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients.

Authors:  Yuquan Bai; Yun Pei; Liang Xia; Lin Ma; Senyi Deng
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

2.  Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis.

Authors:  Wenhua Shi; Wei Feng; Jian Wang; Cui Zhai; Qianqian Zhang; Qingting Wang; Yang Song; Xin Yan; Limin Chai; Pengtao Liu; Yuqian Chen; Cong Li; Manxiang Li
Journal:  J Cancer       Date:  2019-10-04       Impact factor: 4.207

3.  Dynamic nomogram for long-term survival in patients with non-small cell lung cancer after pneumonectomy.

Authors:  Zi-Ming Wang; Marc Swierzy; Dany Balke; Dania Nachira; Diego González-Rivas; Harun Badakhshi; Mahmoud Ismail
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

4.  CT-Derived Body Composition Values and Complications After Pneumonectomy in Lung Cancer Patients: Time for a Sex-Related Analysis?

Authors:  Stefania Rizzo; Francesco Petrella; Claudia Bardoni; Lorenzo Bramati; Andrea Cara; Shehab Mohamed; Davide Radice; Giorgio Raia; Filippo Del Grande; Lorenzo Spaggiari
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

5.  A seven-long noncoding RNA signature predicts overall survival for patients with early stage non-small cell lung cancer.

Authors:  Ting Lin; Yunong Fu; Xing Zhang; Jingxian Gu; Xiaohua Ma; Runchen Miao; Xiaohong Xiang; Wenquan Niu; Kai Qu; Chang Liu; Qifei Wu
Journal:  Aging (Albany NY)       Date:  2018-09-11       Impact factor: 5.682

6.  A six-long noncoding RNA model predicts prognosis in lung adenocarcinoma.

Authors:  Yuquan Bai; Senyi Deng
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.